Table 1.
M1-classically activated macrophages | M2-alternatively activated macrophages | TAM-tumour-associated macrophages | References | |
---|---|---|---|---|
Polarising signals | IFN-γ, LPS or TNF-a | IL-4, IL-13 (M2a), IC+TLR/IL-1R Ligands (M2b), IL-10 (M2c) | CSF-1, VEGF, CCL2/3/4/5/8, IL-4, IL-13, IL-10, TGF-β, PGE2 | [4], [9], [10] |
Membrane receptors | TLR2, TLR4, CD16, CD32, CD64, CD80, CD86 | Scavenge receptor A/B, CD 14, CD 23, CD 163, MR | CD11b, CD45, F4/80 (mice), CXCR4, Gr1,CD68, VEGFR | [4], [9], [10] |
Cytokines released | High IL-12, IL-23, low IL-10, IL-1, TNF, IL-6, ROI, RNI | High IL-10, low IL-12; TGF-β (M2c); low IL-1, TNF, IL-6 (not M2b); high decoy IL-1RII, IL-1R-antagonist, EGF, FGF, VEGF, TNF-β | FGF, PDGF, EGFR, VEGF, ANG1/2, IL-1/8, TNF-α, TP, MMP-2/9, CSF-1 | [4], [9], [10] |
Chemokines released | CXCL 8/9/10/11/16 CCL2/3/4/5 | CCL 1/16/17/18/22/24 | CCL-2/3 | [4], [9], [10] |
Function | Th2 responses, type II inflammation, allergy, killing and encapsulation of parasites | Th2 activation, immunoregulation, matrix deposition and tissue remodelling | Angiogenesis, tumour growth, tumour invasion, intravasation, immunosuppression, metastasis | [4], [9], [10] |
Markers (mouse) | iNOS, CD197 | Arginase-1, CD163 | F4/80 | [4], [9], [10] |
Abbreviations are: IFN, interferon; LPS, lipopolysaccharide; TNF, tumour necrosis factor; IL, interleukin; IC, immune complexes; TLR, toll-like receptor; CSF, colony stimulating factor; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; CCL, CC chemokine ligand; TGF, transforming growth factor; PGE, prostaglandin E; ROI, reactive oxygen intermediates; RNI, reactive nitrogen intermediates; EGF, epidermal growth factor; FGF, fibroblast growth factor; PDGF, platelet-derived growth factor; EGFR, epidermal growth factor receptor; ANG, angiopoietin; MMP, matrix metalloproteinase; CXCL, chemokine (C-X-C motif) ligand.